TY - JOUR
T1 - Pulsed field ablation in the elderly by a pentaspline multielectrode catheter
T2 - Safety, efficacy, and comparison with cryoballoon and radiofrequency devices
AU - HRMC Investigators
AU - Nakasone, Kazutaka
AU - Della Rocca, Domenico G
AU - Magnocavallo, Michele
AU - Betancur, Andres
AU - Vetta, Giampaolo
AU - Pannone, Luigi
AU - Sorgente, Antonio
AU - Audiat, Charles
AU - Rodriguez, Jesus
AU - Doundoulakis, Ioannis
AU - Nekic, Andrija
AU - Velagić, Vedran
AU - Polselli, Marco
AU - Mohanty, Sanghamitra
AU - Marcon, Lorenzo
AU - Sieira, Juan
AU - Ströker, Erwin
AU - Bala, Gezim
AU - Bianchi, Stefano
AU - Almorad, Alexandre
AU - Combes, Stephane
AU - Tsiachris, Dimitrios
AU - Sarkozy, Andrea
AU - Natale, Andrea
AU - Boveda, Serge
AU - Rossi, Pietro
AU - de Asmundis, Carlo
AU - Chierchia, Gian-Battista
N1 - Copyright © 2025 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
PY - 2025/1/24
Y1 - 2025/1/24
N2 - BACKGROUND: Catheter ablation is an effective treatment of atrial fibrillation. Pulsed field ablation (PFA) has emerged as a novel energy modality that relies on high-voltage electric fields to achieve cardiac tissue ablation. Data on its efficacy in the elderly are scarce.OBJECTIVE: This study aimed to evaluate the procedural details and clinical outcomes of PFA in patients >75 years old.METHODS: Consecutive patients with atrial fibrillation >75 years old undergoing PFA with the Farapulse system were enrolled at 6 high-volume centers. Procedural details and clinical outcomes were compared with those of patients undergoing second-generation cryoballoon ablation (CBA) and radiofrequency ablation (RFA).RESULTS: Of 983 patients, 221 underwent PFA, 216 CBA, and 546 RFA. Procedure times were shorter with PFA (72 ± 30 minutes) compared with CBA (77 ± 27 minutes) and RFA (99 ± 23 minutes; P < .001). Extra-pulmonary vein ablation was performed in 74.2% PFA, 9.7% CBA, and 42.1% RFA (P < .001). The major complication rate was 1.01% (n = 10) and was not significantly different between groups (1 PFA, 2 CBA, and 7 RFA; P = .578). Minor complications were observed in 1.4% PFA, 5.1% CBA, and 3.5% RFA (P = .093). The 1-year atrial tachyarrhythmia freedom in the propensity score-matched population was 77.2% with PFA, 80.8% with CBA, and 74.9% with RFA; P = .52).CONCLUSION: PFA is a safe and effective option for elderly patients, offering the advantage of enabling extra-pulmonary vein ablation without the concern of thermal injury risk.
AB - BACKGROUND: Catheter ablation is an effective treatment of atrial fibrillation. Pulsed field ablation (PFA) has emerged as a novel energy modality that relies on high-voltage electric fields to achieve cardiac tissue ablation. Data on its efficacy in the elderly are scarce.OBJECTIVE: This study aimed to evaluate the procedural details and clinical outcomes of PFA in patients >75 years old.METHODS: Consecutive patients with atrial fibrillation >75 years old undergoing PFA with the Farapulse system were enrolled at 6 high-volume centers. Procedural details and clinical outcomes were compared with those of patients undergoing second-generation cryoballoon ablation (CBA) and radiofrequency ablation (RFA).RESULTS: Of 983 patients, 221 underwent PFA, 216 CBA, and 546 RFA. Procedure times were shorter with PFA (72 ± 30 minutes) compared with CBA (77 ± 27 minutes) and RFA (99 ± 23 minutes; P < .001). Extra-pulmonary vein ablation was performed in 74.2% PFA, 9.7% CBA, and 42.1% RFA (P < .001). The major complication rate was 1.01% (n = 10) and was not significantly different between groups (1 PFA, 2 CBA, and 7 RFA; P = .578). Minor complications were observed in 1.4% PFA, 5.1% CBA, and 3.5% RFA (P = .093). The 1-year atrial tachyarrhythmia freedom in the propensity score-matched population was 77.2% with PFA, 80.8% with CBA, and 74.9% with RFA; P = .52).CONCLUSION: PFA is a safe and effective option for elderly patients, offering the advantage of enabling extra-pulmonary vein ablation without the concern of thermal injury risk.
UR - http://www.scopus.com/inward/record.url?scp=85217977705&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2025.01.025
DO - 10.1016/j.hrthm.2025.01.025
M3 - Article
C2 - 39864479
JO - Heart Rhythm
JF - Heart Rhythm
SN - 1547-5271
ER -